Clinical Trial Update: A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden [Phase 4]

View source ↗

Summary

Phase 4 study to evaluate Lebrikizumab in adults and adolescents with moderate atopic dermatitis and high itch burden; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Lebrikizumab (lebrikizumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Atopic Dermatitis | Phase 4 | Status: RECRUITING